AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. | ...
Bevacizumab has been sold as Avastin by originator Roche for many years and used by the NHS for various forms of cancer, with ...
Susan Galbraith, AstraZeneca’s executive vice president for oncology haematology R&D, discussed the setback in a statement. Galbraith said the goal was to “reinvigorate the immune response of patients ...
NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 —— ...
The News Leader on MSN
New Virginia laws on social media, baby food going into effect Jan. 1
Several new laws in Virginia regarding social media, baby food, and healthcare take effect on January 1. Social media ...
Manulife Hong Kong today announced an expansion of its partnership with Hong Kong Baptist Hospital (HKBH) through the launch ...
According to a rumor that circulated online in late 2025, Speaker of the House Mike Johnson, R-La., gives away nearly all his ...
We have a lot of misconceptions when it comes to health and wellness, from the cold-fighting powers of Vitamin C to whatever ...
Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...
News-Medical.Net on MSN
Dihydrotanshinone I induces autophagic cell death in ovarian cancer
A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...
Experts from Cancer Research UK share how through world-class research, we can better understand and tackle the impacts of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results